Swiss stocks – Factors to watch on Oct 29

ZURICH, Oct 29 (BestGrowthStock) – Swiss stocks were expected to
open lower on Friday, in line with markets across Europe, ahead
of a raft of economic releases, which could shed light on the
U.S. Federal Reserve’s likely move next week.

The Swiss blue-chip index SMI (.SSMI: ) was indicated to fall
17 points to 6,468 points, premarket data provided by bank
Clariden Leu showed. (CLPRE: )

The following are some of the main factors expected to
affect Swiss stocks on Friday:


Roche Holding AG’s cancer drug MabThera can now be used as a
first line maintenance treatment for follicular lymphoma, a
common form of blood cancer, broadening the drug’s use and
giving Roche a boost.

For related news, click on [ROG.VX]


Nestle will distribute an extra 600,000 disease-resistant
cocoa trees to farmers in Ivory Coast during the 2010/11 cocoa
season, after handing out 140,000 trees so far, its Africa
research director said on Thursday.

For related news, click on [NESN.VX]


Japan’s Dainippon Sumitomo Pharma Co Ltd (4506.T: ) said its
oral schizophrenia pill got marketing approval from the U.S.
health regulator.

The Osaka-based company will now compete with Novartis’
twice-daily oral pill Fanapt in the schizophrenia market in the
United States.

For related news, click on [NOVN.VX]


* The Swiss National Bank’s expansionary policy is
appropriate and there is no reason at present to intervene in
the currency market given the inflation outlook, Swiss central
bankers said on Thursday.[ID:nLDE69R25V]

* Swiss KOF leading economic barometer for Oct. due 0930 GMT
is expected to dip slightly from 2.21 in Sept.(ECONCH: )


* Meyer Burger (MBTN.S: ) increases guidance on net sales for
fiscal year 2010 [MBTN.S]

* Zueblin (ZUBN.S: ) announces solid preliminary half-year
results for 2010/2011 [ZUBN.S]

* Ypsomed (YPSN.S: ) launches new reusable ServoPen in China

* Implenia (IMPN.S: ), as total contractor, made the
breakthrough in the 471-meter-long Allmend tunnel on 26 October
2010. This marks a key milestone in the project to lower the
Lucerne Zentralbahn railway and expand it to two tracks.


* UBS raises Logitech (LOGN.VX: ) price target to 22 Sfr 21
Sfr; rating buy

* JP Morgan cuts ABB (ABBN.VX: ) price target to 24.50 Sfr
from 25 Sfr; rating overweight


(.EX.S: ) for all Swiss stocks

(.EXSMI.S: ) for blue chips

(.EXNSMI.S: ) for other stocks

Swiss stocks – Factors to watch on Oct 29